Showing results (221-230 of 332) with videos related to
Sort By:
Pageof 34
European Journal of Neurology|March 2, 2021
Untreated patients with multiple sclerosis: A study of French expert centersXavier Moisset, Audrey-Anne Fouchard, Bruno Pereira, et al.Neurology|September 25, 2024
Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis: A Multicenter Real-Life StudyMarion Hay, Fabien Rollot, Romain Casey, et al.Annals of Clinical and Translational Neurology|June 29, 2025
Relevance of Kappa and Lambda Free Light Chains in Autoimmune Astrocytopathy Associated With Anti-GFAP AntibodiesMichael Levraut, Romain Marignier, Mikael Cohen, et al.JAMIA Open|May 14, 2026
PRIMUS: a precision medicine platform reusing clinical trials and registry data to support treatment selection in multiple sclerosisStanislas Demuth, Igor Faddeenkov, Julien Paris, et al.Brain : a Journal of Neurology|July 24, 2009
Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 casesPierre Labauge, Laetitia Horzinski, Xavier Ayrignac, et al.The Lancet. Neurology|March 17, 2023
Family planning considerations in people with multiple sclerosisKristen M Krysko, Ruth Dobson, Raed Alroughani, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|January 11, 2025
Analysis of healthcare utilization before the diagnosis of radiologically isolated syndromeChristine Lebrun-Frenay, Sandrine Kerbrat, Darin T Okuda, et al.JAMA Network Open|October 11, 2021
Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated SyndromeChristine Lebrun-Frénay, Fabien Rollot, Lydiane Mondot, et al.JAMA Neurology|September 4, 2019
Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in FranceSandra Vukusic, Fabien Rollot, Romain Casey, et al.Neurology|July 30, 2025
Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple SclerosisAntoine Gavoille, Emmanuelle Leray, Romain Marignier, et al.Pageof 34